Physician profile
Blair Smith
NPI 1174835136
$3,498.79
in general payments reported to CMS, 2019-2025
13 companies · $21.97 in 2025
The $21.97 reported for 2025 was less than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,712 · 2020: $94.32 · 2021: $18.58 · 2022: $273 · 2023: $131 · 2024: $248 · 2025: $21.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $400.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,132.58 | 2019-2024 | |
| Myriad Genetic Laboratories, INC. | $312.91 | 2023-2024 | Myrisk |
| Gynesonics, INC. | $273.29 | 2022 | |
| Merck Sharp & Dohme LLC | $229.47 | 2019-2024 | Keytruda |
| Edwards Lifesciences Corporation | $146.04 | 2019 | |
| Tesaro, INC. | $116.75 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $103.93 | 2019-2021 | |
| Clovis Oncology, INC. | $91.88 | 2019-2020 | |
| Astellas Pharma US INC | $24.13 | 2019 | |
| Genmab U.S., INC. | $21.97 | 2025 | Tivdak |
| Kyowa Kirin, INC. | $15.81 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $15.64 | 2019 | |
| Axonics, INC. | $14.39 | 2023 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blair Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.